S
CRL icon

Storgate’s Charles River Laboratories CRL Stock Holding History

Storgate’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$658K Buy
2,902
+1,504
+108% +$268K 0.14% 173
2026
Q1 		$241K Buy
1,398
+83
+6% +$15.4K 0.19% 144
2025
Q4 		$262K Buy
+1,315
New +$239K 0.22% 133

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Storgate's CRL Position: Q2 2026 in Review

Storgate increased its Charles River Laboratories (CRL) stake by 108% in Q2 2026, buying an estimated $268K and bringing the position to 2,902 shares worth $658K. The position accounts for 0.14% of the portfolio, ranked #173.

Storgate first reported a position in CRL in Q4 2025 and has held it in 3 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Storgate held 2,902 shares of Charles River Laboratories worth $658K as of Q2 2026.
  • Storgate bought 1,504 Charles River Laboratories shares in Q2 2026, an estimated $268K.
  • Charles River Laboratories made up 0.14% of Storgate's portfolio in Q2 2026, its #173 holding.
  • Storgate first reported a position in Charles River Laboratories in Q4 2025 and has held it in 3 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Storgate's 13F filing for Q2 2026, filed 12 Aug 2026.